SCHEMBL6159152

SCHEMBL6159152

CCSC1CC(=O)N(Cc2ccc(Oc3ccccc3)cc2)C1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
NPSR1 Q6W5P4 1/20 0.49
KMT2A Q03164 3/20 0.48
TDP1 Q9NUW8 1/20 0.48
GAA P10253 3/20 0.45
TSHR P16473 3/20 0.45
HSD17B10 Q99714 1/20 0.45
MEN1 O00255 1/20 0.43
LMNA P02545 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
HPGD P15428 1/20 0.43
CYP2C19 P33261 1/20 0.43
STAT6 P42226 1/20 0.43
HCRTR1 O43613 3/20 0.43
HCRTR2 O43614 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
MT-CO2 P00403 1/20 0.42
ALOX5 P09917 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6158988 0.88 ALDH1A1 (0.53) ALDH1A1NPSR1KMT2ATDP1GAA
SCHEMBL6157032 0.87 ALDH1A1 (0.54) ALDH1A1NPSR1KMT2ATDP1GAA
SCHEMBL6158601 0.83 ALDH1A1 (0.48) ALDH1A1NPSR1KMT2ATDP1GAA
SCHEMBL6158906 0.83 ALDH1A1 (0.48) ALDH1A1NPSR1KMT2ATDP1GAA
SCHEMBL6158480 0.80 ALDH1A1 (0.47) ALDH1A1NPSR1KMT2ATDP1GAA
SCHEMBL7082507 0.78 ALDH1A1 (0.48) ALDH1A1KMT2AGAATSHRHSD17B10
SCHEMBL6157379 0.78 ALDH1A1 (0.48) ALDH1A1KMT2AGAATSHRHSD17B10
SCHEMBL6160115 0.78 SMN1; SMN2 (0.47) ALDH1A1KMT2AGAATSHRHSD17B10
SCHEMBL6164828 0.75 MT-CO2 (0.53) ALDH1A1KMT2AGAATSHRHSD17B10
SCHEMBL6158680 0.74 HCRTR1 (0.46) ALDH1A1NPSR1HCRTR1HCRTR2MT-CO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6953789-B2 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-10-11 US disclosed
US-20040157894-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-08-12 US disclosed
US-6699881-B2 MATRIX METALLOPROTEASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-03-02 US disclosed
US-20030078253-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY, LIMITED (JP) 2003-04-24 US disclosed
US-6420415-B1 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-07-16 US disclosed
EP-1132379-A1 NOVEL THIOL DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-09-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078253-A1 Thiol compounds, their production and use TST, QSOX1, SULT1E1 ALDH1A1 905/4885NPSR1 1036/4885KMT2A 1898/4885
US-20040157894-A1 Thiol compounds, their production and use TST, SULT1E1, QSOX1 ALDH1A1 877/4885NPSR1 1120/4885KMT2A 1850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.